We are live on
!
Find out more
GCP
GSA Capital Partners Portfolio holdings
AUM
$1.59B
1-Year Est. Return
39.81%
This Fund
S&P 500
This Quarter
Est. Return
-2.76%
1 Year Est. Return
+39.81%
3 Year Est. Return
+94.75%
5 Year Est. Return
+73.44%
10 Year Est. Return
+404.29%
AUM
$754M
AUM Growth
+$87.8M
(+13%)
Cap. Flow
+$160M
Cap. Flow
% of AUM
21.21%
Top 10 Holdings %
Top 10 Hldgs %
3.31%
Holding
2,028
New
691
Increased
437
Reduced
328
Closed
568
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Dave & Buster's
PLAY
|
+$2.84M |
| 2 |
Live Nation Entertainment
LYV
|
+$2.81M |
| 3 |
Wolverine World Wide
WWW
|
+$2.72M |
| 4 |
Tesla
TSLA
|
+$2.63M |
| 5 |
CALY
Callaway Golf Company
CALY
|
+$2.58M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Genpact
G
|
+$3.61M |
| 2 |
Relay Therapeutics
RLAY
|
+$2.99M |
| 3 |
Extreme Networks
EXTR
|
+$2.33M |
| 4 |
Casey's General Stores
CASY
|
+$2.21M |
| 5 |
GTHX
G1 Therapeutics, Inc. Common Stock
GTHX
|
+$2.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 16.63% |
| 2 | Consumer Discretionary | 15.71% |
| 3 | Technology | 14.34% |
| 4 | Industrials | 12% |
| 5 | Financials | 11.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
776
Tenet Healthcare
THC
$21.1B
| $380K | 0.05% |
+7,361
| New | +$437K |
|
777
Adicet Bio
ACET
$74.7M
| $379K | 0.05% |
+1,665
| New | +$423K |
|
778
TAL Education Group
TAL
$6.87B
| $379K | 0.05% |
76,677
+40,103
| +110% | +$199K |
|
779
Arrowhead Research
ARWR
$12.4B
| $378K | 0.05% |
11,447
-18,794
| -62% | -$758K |
|
780
SandRidge Energy
SD
$503M
| $378K | 0.05% |
+23,204
| New | +$419K |
|
|
EGIO
781
DELISTED
Edgio, Inc. Common Stock
EGIO
| $378K | 0.05% |
3,403
-1,988
| -37% | -$235K |
|
782
Hilltop Holdings
HTH
$2.24B
| $377K | 0.05% |
15,179
+434
| +3% | +$11.8K |
|
783
Mattel
MAT
$4.23B
| $377K | 0.05% |
+19,930
| New | +$446K |
|
784
NETSCOUT
NTCT
$2.79B
| $377K | 0.05% |
+12,026
| New | +$393K |
|
785
Standard Motor Products
SMP
$911M
| $376K | 0.05% |
+11,559
| New | +$460K |
|
786
Bally's
BALY
$658M
| $375K | 0.05% |
+18,991
| New | +$435K |
|
|
PRFT
787
DELISTED
Perficient Inc
PRFT
| $375K | 0.05% |
+5,775
| New | +$482K |
|
|
MZTI
788
The Marzetti Company
MZTI
$3.11B
| $374K | 0.05% |
+2,492
| New | +$370K |
|
789
Weis Markets
WMK
$1.86B
| $374K | 0.05% |
5,254
-10,950
| -68% | -$854K |
|
|
LUNA
790
DELISTED
Luna Innovations Incorporated
LUNA
| $374K | 0.05% |
+84,202
| New | +$481K |
|
|
GOEV
791
DELISTED
Canoo Inc. Class A Common Stock
GOEV
| $372K | 0.05% |
431
-661
| -61% | -$964K |
|
792
Intapp
INTA
$2.91B
| $371K | 0.05% |
+19,867
| New | +$312K |
|
|
EDR
793
DELISTED
Endeavor Group Holdings, Inc.
EDR
| $371K | 0.05% |
18,328
-13,152
| -42% | -$297K |
|
|
NOAH
794
Noah Holdings
NOAH
$603M
| $369K | 0.05% |
27,957
+1,775
| +7% | +$30.2K |
|
795
Corteva
CTVA
$51.3B
| $368K | 0.05% |
+6,434
| New | +$375K |
|
796
Interparfums
IPAR
$3.94B
| $368K | 0.05% |
4,879
+408
| +9% | +$32.3K |
|
|
KZR
797
DELISTED
Kezar Life Sciences
KZR
| $368K | 0.05% |
4,269
+1,736
| +69% | +$169K |
|
|
RCM
798
DELISTED
R1 RCM Inc. Common Stock
RCM
| $368K | 0.05% |
+19,873
| New | +$453K |
|
|
AYX
799
DELISTED
Alteryx Inc
AYX
| $368K | 0.05% |
+6,587
| New | +$386K |
|
|
SPNE
800
DELISTED
SeaSpine Holdings Corporation Common Stock
SPNE
| $368K | 0.05% |
64,750
+43,128
| +199% | +$274K |
|
Similar funds
NCL
DG
VNT
SS
GWANC
LCM
LCM
FDCP
GSA Capital Partners's Q3 2022 Portfolio in Review
As of Q3 2022, GSA Capital Partners held 2,028 positions worth $754M, up 13% from $666M the previous quarter. Its ten largest holdings account for 3.3% of the portfolio.
GSA Capital Partners deployed $160M of net new capital in Q3 2022, opening 691 new positions and adding to 437 existing holdings. Its largest new stake was Dave & Buster's: 75,954 shares worth $2.36M.
By sector, the portfolio is most concentrated in Healthcare at 17% of assets, down from 18% a quarter earlier, followed by Consumer Discretionary and Technology.
On the sell side, the largest reduction was Genpact, an estimated $3.61M trimmed.
- GSA Capital Partners's largest Q3 2022 buy was Dave & Buster's: 75,954 shares worth $2.36M.
- GSA Capital Partners added most to Grocery Outlet in Q3 2022, an estimated $2.54M increase.
- GSA Capital Partners's biggest Q3 2022 reduction was Genpact, cutting an estimated $3.61M.
- GSA Capital Partners fully exited Relay Therapeutics in Q3 2022, selling an estimated $2.99M.
- GSA Capital Partners's ten largest holdings make up 3.3% of its $754M portfolio in Q3 2022.
- GSA Capital Partners opened 691 new positions and closed 568 in Q3 2022.
- GSA Capital Partners's portfolio value rose 13% quarter-over-quarter to $754M.
Based on GSA Capital Partners's 13F filing for Q3 2022, filed 14 Nov 2022.